Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease

References

• Kheradmand F, Zhang Y, Corry DB. Contribution of adaptive immunity to human COPD and experimental models of emphysema. Physiol Rev. 2023;103(2):1059–1093. doi:10.1152/physrev.00036.2021
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Gupta A, Janmeja AK, et al. Evaluation of tuberculosis-associated chronic obstructive pulmonary disease at a tertiary care hospital: a case-control study. Lung India. 2017;34(5):415–419. doi:10.4103/lungindia.lungindia_522_16
   PubMedGoogle Scholar
• Mp S, Mohanty Mohapatra M, Mahesh Babu V, et al. Metabolic syndrome in post-pulmonary tuberculosis-associated obstructive airway disease: a cross-sectional analytical study. Cureus. 2022;14(3):e23640. doi:10.7759/cureus.23640
   PubMed Web of Science ®Google Scholar
• Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/S0140-6736(22)00470-6
   PubMed Web of Science ®Google Scholar
• Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration. 2013;86(1):76–85. doi:10.1159/000350917
   PubMed Web of Science ®Google Scholar
• Starshinova A, Malkova A, Zinchenko Y, et al. Identification of autoimmune markers in pulmonary tuberculosis. Front Immunol. 2022;13:1059714. doi:10.3389/fimmu.2022.1059714
   PubMed Web of Science ®Google Scholar
• Belyaeva IV, Kosova AN, Vasiliev AG. Tuberculosis and autoimmunity. Pathophysiology. 2022;29(2):298–318. doi:10.3390/pathophysiology29020022
   PubMedGoogle Scholar
• Chen S, Chen J, Chen L, et al. Mycobacterium tuberculosis infection is associated with the development of erythema nodosum and nodular vasculitis. PLoS One. 2013;8(5):e62653. doi:10.1371/journal.pone.0062653
   PubMed Web of Science ®Google Scholar
• Hardy R. R B-1 B cell development. J Immunol. 2006;177(5):2749–2754. doi:10.4049/jimmunol.177.5.2749
   PubMed Web of Science ®Google Scholar
• Campisi L, Barbet G, Ding Y, et al. Apoptosis in response to microbial infection induces autoreactive TH17 cells. Nature Immunol. 2016;17(9):1084–1092. doi:10.1038/ni.3512
   PubMed Web of Science ®Google Scholar
• Schrijver B, Hardjosantoso H, Ten Berge J, et al. No evidence for circulating retina specific autoreactive T-cells in latent tuberculosis-associated uveitis and sarcoid uveitis. Ocul Immunol Inflamm. 2021;29(5):883–889. doi:10.1080/09273948.2019.1698752
   PubMed Web of Science ®Google Scholar
• Tagirasa R, Parmar S, Barik MR, et al. Autoreactive T cells in immunopathogenesis of TB-associated uveitis. Invest Ophthalmol Vis Sci. 2017;58(13):5682–5691. doi:10.1167/iovs.17-22462
   PubMed Web of Science ®Google Scholar
• Kuo CJ, Ptak CP, Hsieh CL, et al. Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex. J Biol Chem. 2013;288(6):3886–3896. doi:10.1074/jbc.M112.415679
   PubMed Web of Science ®Google Scholar
• Patel KJ, Cheng Q, Stephenson S, et al. Emphysema-associated autoreactive antibodies exacerbate post-lung transplant ischemia-reperfusion injury. Am J Respir Cell Mol Biol. 2019;60(6):678–686. doi:10.1165/rcmb.2018-0224OC
   PubMed Web of Science ®Google Scholar
• Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc. 2007;4(7):512–521. doi:10.1513/pats.200701-002FM
   PubMedGoogle Scholar
• Luo XM, Liu XY, Tang JH, et al. Autoantibodies against CD80 in patients with COPD. Clin Transl Immunol. 2016;5(10):e103. doi:10.1038/cti.2016.57
   PubMed Web of Science ®Google Scholar
• Wen L, Krauss-Etschmann S, Petersen F, et al. Autoantibodies in chronic obstructive pulmonary disease. Front Immunol. 2018;9:66. doi:10.3389/fimmu.2018.00066
   PubMed Web of Science ®Google Scholar
• Nakiyingi L, Nankabirwa H, Lamorde M. Tuberculosis diagnosis in resource-limited settings: clinical use of GeneXpert in the diagnosis of smear-negative PTB: a case report. Afr Health Sci. 2013;13(2):522–524. doi:10.4314/ahs.v13i2.46
   PubMed Web of Science ®Google Scholar
• Li FS, Zhang YL, Li Z, et al. Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage. Exp Ther Med. 2016;12(4):2477–2488. doi:10.3892/etm.2016.3680
   PubMed Web of Science ®Google Scholar
• Johannet P, Liu W, Fenyo D. Baseline serum autoantibody signatures predict recurrence and toxicity in melanoma patients receiving adjuvant immune checkpoint blockade. Clin Cancer Res. 2022;28(18):4121–4130. doi:10.1158/1078-0432.CCR-22-0404
   PubMed Web of Science ®Google Scholar
• Cheng P, Wang L, Gong W. In silico analysis of peptide-based biomarkers for the diagnosis and prevention of latent tuberculosis infection. Front Microbiol. 2022;13:947852. doi:10.3389/fmicb.2022.947852
   PubMed Web of Science ®Google Scholar
• Soria-Guerra RE, Nieto-Gomez R, Govea-Alonso DO, et al. An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J Biomed Inform. 2015;53:405–414. doi:10.1016/j.jbi.2014.11.003
   PubMed Web of Science ®Google Scholar
• Place DE, Kanneganti T-D. Place D EKanneganti T D The innate immune system and cell death in autoinflammatory and autoimmune disease. Curr Opin Immunol. 2020;67:95–105. doi:10.1016/j.coi.2020.10.013
   PubMed Web of Science ®Google Scholar
• Sarkar M, Madabhavi I, Kumar K. Tuberculosis associated chronic obstructive pulmonary disease. Clin Respir J. 2017;11(3):285–295. doi:10.1111/crj.12621
   PubMed Web of Science ®Google Scholar
• Yakar HI, Gunen H, Pehlivan E, et al. The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:323–329. doi:10.2147/COPD.S116086
   PubMed Web of Science ®Google Scholar
• Katare S, Harsha A. Correlations between inflammatory biomarkers in tuberculosis-associated obstructive pulmonary disease patients with anxiety and depression. Cureus. 2022;14(3):e22742. doi:10.7759/cureus.22742
   PubMed Web of Science ®Google Scholar
• Oh JY, Lee YS, Min KH, et al. Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3381–3387. doi:10.2147/COPD.S177371
   PubMed Web of Science ®Google Scholar
• Park HJ, Byun MK, Kim HJ. History of pulmonary tuberculosis affects the severity and clinical outcomes of COPD. Respirology (Carlton, Vic). 2018;23(1):100–106. doi:10.1111/resp.13147
   PubMed Web of Science ®Google Scholar
• Allwood BW, Rigby J, Griffith-Richards S, et al. Histologically confirmed tuberculosis-associated obstructive pulmonary disease. Int J Tuberc Lung Dis. 2019;23(5):552–554. doi:10.5588/ijtld.18.0722
   PubMed Web of Science ®Google Scholar
• Starshinova A, Malkova А, Kudryavtsev I, et al. Tuberculosis and autoimmunity: common features. Tuberculosis (Edinb). 2022;134:102202. doi:10.1016/j.tube.2022.102202
   PubMed Web of Science ®Google Scholar
• Mukherjee M, Bulir CD, Radford K, et al. Sputum autoantibodies in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 2018;141(4):1269–1279. doi:10.1016/j.jaci.2017.06.033
   PubMed Web of Science ®Google Scholar
• Ma A, Wen L, Yin J, et al. Serum levels of autoantibodies against extracellular antigens and neutrophil granule proteins increase in patients with COPD compared to non-COPD smokers. Int J Chronic Obstr. 2020;15:189–200. doi:10.2147/COPD.S235903
   PubMed Web of Science ®Google Scholar
• Lee DS, WRojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nature Rev Drug Discov. 2021;20(3):179–199. doi:10.1038/s41573-020-00092-2
   PubMed Web of Science ®Google Scholar
• Eggenhuizen PJ, Ng BH, Ooi JD. Treg Enhancing Therapies to Treat Autoimmune Diseases. Int J Mol Sci. 2020;21(19):7015. doi:10.3390/ijms21197015
   PubMed Web of Science ®Google Scholar
• Quiros-Roldan E, Sottini A, Signorini SG, et al. Autoantibodies to Interferons in Infectious Diseases. Viruses. 2023;15(5):1215. doi:10.3390/v15051215
   PubMed Web of Science ®Google Scholar
• Nagele EP, Han M, Acharya NK, et al. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease. PLoS One. 2013;8(4):e60726. doi:10.1371/journal.pone.0060726
   PubMed Web of Science ®Google Scholar
• Byrne R, Todd I, Tighe PJ, et al. Autoantibodies in chronic obstructive pulmonary disease: a systematic review. Immunol Lett. 2019;214:8–15. doi:10.1016/j.imlet.2019.08.007
   PubMed Web of Science ®Google Scholar
• Cass SP, Dvorkin-Gheva A, Yang Y, et al. Differential expression of sputum and serum autoantibodies in patients with chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2021;320(6):L1169–l1182.
   PubMed Web of Science ®Google Scholar
• Shen CY, Hsieh SC, Yu CL, et al. Autoantibody prevalence in active tuberculosis: reactive or pathognomonic? BMJ Open. 2013;3(7):e002665. doi:10.1136/bmjopen-2013-002665
   PubMed Web of Science ®Google Scholar
• Goodridge A, Cueva C, Lahiff M, et al. Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response. Tuberculosis (Edinb). 2012;92(3):243–247. doi:10.1016/j.tube.2012.02.004
   PubMed Web of Science ®Google Scholar
• Apostólico JDS, Lunardelli VAS, Coirada FC, Boscardin SB, Rosa DS. Adjuvants: classification, modus operandi, and licensing. J Immunol Res. 2016;2016:1459394. doi:10.1155/2016/1459394
   PubMed Web of Science ®Google Scholar
• You Z, Li Y, Wang Q. The Clinical Significance of Hepatic CD69(+) CD103(+) CD8(+) resident-memory T cells in autoimmune hepatitis. Hepatology (Baltimore, Md). 2021;74(2):847–863. doi:10.1002/hep.31739
   PubMed Web of Science ®Google Scholar
• Rubtsov AV, Marrack P, Rubtsova K. T-bet expressing B cells – novel target for autoimmune therapies? Cel Immunol. 2017;321:35–39. doi:10.1016/j.cellimm.2017.04.011
   PubMed Web of Science ®Google Scholar
• Imperiale BR, García A, Minotti A, et al. Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis. Clin Exp Immunol. 2021;203(2):267–280. doi:10.1111/cei.13544
   PubMed Web of Science ®Google Scholar
• Li L, Jiang Y, Lao S, et al. Mycobacterium tuberculosis-specific IL-21+IFN-γ+CD4+ T cells are regulated by IL-12. PLoS One. 2016;11(1):e0147356. doi:10.1371/journal.pone.0147356
   PubMed Web of Science ®Google Scholar
• Funes SC, Rios M, Escobar-Vera J, et al. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154(2):186–195. doi:10.1111/imm.12910
   PubMed Web of Science ®Google Scholar
• Kushnareva Y, Mathews IT, Andreyev AY. Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production. J Immunol. 2021;206(6):1181–1193. doi:10.4049/jimmunol.2000672
   PubMed Web of Science ®Google Scholar
• Pathak VK, Singh I, Singh SV, et al. Mimicking B and T cell epitopes between Mycobacterium leprae and host as predictive biomarkers in type 1 reaction in leprosy. Sci Rep. 2021;11(1):24431. doi:10.1038/s41598-021-04135-5
   PubMed Web of Science ®Google Scholar